Vital Farms (NASDAQ:VITL) Posts Quarterly Earnings Results, Hits Expectations

Vital Farms (NASDAQ:VITL) released its earnings results on Thursday. The company reported ($0.47) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.47), FiscalAI reports. Vital Farms had a return on equity of 14.47% and a net margin of 6.10%.The company had revenue of $166.03 million during the quarter, compared to the consensus estimate of $160.24 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. The firm’s quarterly revenue was down 10.2% on a year-over-year basis.

Here are the key takeaways from Vital Farms’ conference call:

• Q2 results deteriorated sharply: net revenue fell 10.1% to $166 million and adjusted EBITDA was a $26.6 million loss, driven by excess egg supply, $19.5 million in breaker-sale impacts, and other discrete costs.
• Management said the turnaround is gaining traction, citing price-gap reductions, a more than 200-basis-point year-over-year increase in retail dollar share, and a 12.5% sequential rise in shell-egg units per store per week by mid-July.
• Distribution expansion remains a major growth driver, with 2026 average TDPs expected at 150–160 and fourth-quarter TDPs projected at 170–175, supported by new placements across mass, grocery, and natural channels.
• Vital Farms reaffirmed full-year guidance of $775 million–$800 million in net revenue and $0 million–$10 million in adjusted EBITDA, expecting second-half improvement from lower breaker costs, increased retail volume, and $6 million–$7 million in annualized SG&A savings.
• The company strengthened liquidity with a new $125 million term loan and $60 million asset-based lending facility, but terminated its share-repurchase program and paused Vital Crossroads construction to prioritize cash preservation.

Vital Farms Trading Down 2.2%

NASDAQ VITL traded down $0.27 on Friday, reaching $12.24. The company had a trading volume of 2,737,682 shares, compared to its average volume of 2,535,982. The stock’s 50 day moving average is $11.83 and its 200-day moving average is $15.60. The stock has a market cap of $524.48 million, a price-to-earnings ratio of 11.77 and a beta of 1.07. The company has a quick ratio of 1.00, a current ratio of 1.77 and a debt-to-equity ratio of 0.01. Vital Farms has a 52 week low of $7.95 and a 52 week high of $53.13.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on VITL shares. Stifel Nicolaus set a $11.00 price objective on Vital Farms in a report on Friday. Mizuho set a $20.00 target price on shares of Vital Farms in a research note on Monday, May 4th. Needham & Company LLC lifted their price target on shares of Vital Farms from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Friday. William Blair reiterated a “market perform” rating on shares of Vital Farms in a research report on Friday, May 8th. Finally, DA Davidson set a $14.00 price target on shares of Vital Farms in a research note on Friday. Six investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Vital Farms currently has an average rating of “Hold” and an average target price of $20.75.

Key Stories Impacting Vital Farms

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Analyst sentiment improved: Needham raised its price target from $13 to $14 and assigned a “Buy” rating, implying approximately 14.4% upside. Benchmark also upgraded Vital Farms from “Hold” to “Buy.” Needham price target update Benchmark upgrade
• Positive Sentiment: Revenue exceeded expectations: Second-quarter revenue was $166.03 million, ahead of the $160.24 million analyst estimate. Management’s fiscal 2026 revenue outlook of $775 million to $800 million was described as optimistic and is broadly aligned with the $778.3 million consensus forecast. Vital Farms second-quarter results
• Neutral Sentiment: Earnings were roughly in line: Vital Farms reported a second-quarter loss of $0.47 per share, approximately matching consensus estimates, although estimates varied slightly among data providers. The company’s earnings call transcript provides additional management commentary on the results and outlook. Q2 2026 earnings call transcript
• Negative Sentiment: Profitability weakened: Revenue declined 10.2% year over year, and the quarterly result compares with earnings of $0.36 per share in the same period last year, highlighting significant year-over-year earnings pressure. Vital Farms Q2 earnings report
• Negative Sentiment: New borrowing adds financial risk: Silver Point Capital led a $125 million term-loan financing for Vital Farms. The funding may support operations or growth, but it also increases leverage and future interest obligations. Vital Farms term loan financing

Insider Buying and Selling

In related news, insider Peter Nicholas Pappas purchased 3,500 shares of the stock in a transaction dated Thursday, May 14th. The stock was bought at an average cost of $8.51 per share, with a total value of $29,785.00. Following the purchase, the insider directly owned 85,169 shares in the company, valued at $724,788.19. The trade was a 4.29% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, insider Joseph Michael Holland purchased 12,484 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The stock was purchased at an average price of $8.00 per share, for a total transaction of $99,872.00. Following the completion of the transaction, the insider directly owned 38,150 shares in the company, valued at $305,200. This trade represents a 48.64% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders bought 38,700 shares of company stock worth $320,864. Corporate insiders own 3.90% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Royal Bank of Canada boosted its position in shares of Vital Farms by 89.2% during the first quarter. Royal Bank of Canada now owns 19,381 shares of the company’s stock worth $591,000 after purchasing an additional 9,136 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Vital Farms by 5.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company’s stock valued at $611,000 after buying an additional 1,108 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in Vital Farms by 3.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company’s stock worth $12,658,000 after buying an additional 13,397 shares during the period. Woodline Partners LP acquired a new stake in Vital Farms during the 1st quarter worth $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Vital Farms by 1.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company’s stock worth $2,739,000 after acquiring an additional 1,198 shares in the last quarter. Institutional investors and hedge funds own 98.59% of the company’s stock.

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.